Contents

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Volume 2 - Number 2

Cyclopentenone Prostaglandins as Anti-Inflammatory Agents: A Novel Therapeutic Strategy?

, 2(2): 85 - 93

A. Ianaro, P. Maffia, M. Di Rosa and A. Ialenti


DOI: 10.2174/1568014033483851




Modulation of Interleukin-10 Production by Therapeutic Drugs

, 2(2): 95 - 106

Bernard Royer, Jean-Pierre Kantelip and Michel Arock


DOI: 10.2174/1568014033483815




New Approaches for the Treatment of Allergic Conditions

, 2(2): 107 - 118

Csaba Rusznak


DOI: 10.2174/1568014033483833




Strategies for Leukotriene Modulation in Dermatology: Current Evidence and Visionary Perspectives

, 2(2): 119 - 130

Giovanni Luigi Capella


DOI: 10.2174/1568014033483798




Mitogen-Activated Protein Kinases: New Molecular Targets for Pharmacological Treatment of Inflammatory Lung Diseases

, 2(2): 131 - 141

G. Pelaia, G. Cuda, A. Vatrella, D. Fratto, P. Tagliaferri, R. Maselli, F. S. Costanzo and S. A. Marsico


DOI: 10.2174/1568014033483770




From Hygiene Hypothesis to Novel Allergic Asthma Therapeutics

, 2(2): 143 - 155

I. Sayers, G. Le Gros and J. L. Harper


DOI: 10.2174/1568014033483842




Role of Peripheral Tachykinin Receptors in Neurogenic Inflammation of the Respiratory, Genitourinary and Gastrointestinal Systems

, 2(2): 157 - 174

Stefano Evangelista, Riccardo Patacchini and Carlo Alberto Maggi


DOI: 10.2174/1568014033483789




Chemokines as Therapeutic Targets for Renal Diseases

, 2(2): 175 - 190

Takashi Wada, Kouji Matsushima and Hitoshi Yokoyama


DOI: 10.2174/1568014033483824




Pharmacological Targets for the Inhibition of Neurogenic Inflammation

, 2(2): 191 - 218

Zsuzsanna Helyes, Erika Pinter, Jozsef Nemeth and Janos Szolcsanyi


DOI: 10.2174/1568014033483806




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science